- Report
- May 2025
- 115 Pages
Global
From €4256EUR$4,750USD£3,646GBP
- Report
- June 2025
- 400 Pages
Global
From €4434EUR$4,949USD£3,798GBP
- Report
- August 2022
- 117 Pages
Global
From €4256EUR$4,750USD£3,646GBP
- Report
- May 2026
- 69 Pages
India
From €4256EUR$4,750USD£3,646GBP
- Report
- February 2024
- 120 Pages
Global
From €4256EUR$4,750USD£3,646GBP
- Report
- February 2024
- 71 Pages
Europe
From €4256EUR$4,750USD£3,646GBP
- Report
- February 2024
- 120 Pages
Global
From €4256EUR$4,750USD£3,646GBP
- Report
- April 2023
- 120 Pages
Global
From €4256EUR$4,750USD£3,646GBP
- Report
- April 2023
- 106 Pages
Global
From €4256EUR$4,750USD£3,646GBP
- Report
- April 2023
- 100 Pages
Global
From €4256EUR$4,750USD£3,646GBP
- Report
- April 2023
- 61 Pages
Mexico
From €4256EUR$4,750USD£3,646GBP
- Report
- December 2024
- 150 Pages
Global
From €3360EUR$3,750USD£2,878GBP
- Report
- July 2024
- 100 Pages
Global
From €3360EUR$3,750USD£2,878GBP
- Report
- July 2024
- 100 Pages
Global
From €3360EUR$3,750USD£2,878GBP
- Report
- July 2024
- 100 Pages
Global
From €3360EUR$3,750USD£2,878GBP
- Report
- June 2024
- 200 Pages
Global
From €7123EUR$7,950USD£6,102GBP
- Report
- November 2023
- 113 Pages
Global
From €6720EUR$7,500USD£5,756GBP
- Report
- June 2022
- 320 Pages
Global
From €12454EUR$13,900USD£10,668GBP
- Report
- August 2024
- 150 Pages
Global
From €3360EUR$3,750USD£2,878GBP
- Report
- July 2024
- 150 Pages
Global
From €3360EUR$3,750USD£2,878GBP

Retinopathy is a medical condition that affects the retina, the light-sensitive tissue at the back of the eye. It is a leading cause of blindness and visual impairment worldwide. Optical treatments for retinopathy include laser photocoagulation, intravitreal injections, and vitrectomy. Laser photocoagulation is used to reduce the risk of vision loss by sealing off leaking blood vessels in the retina. Intravitreal injections are used to deliver medications directly to the retina to reduce swelling and inflammation. Vitrectomy is a surgical procedure used to remove scar tissue and other debris from the vitreous cavity.
Companies in the retinopathy market include Alcon, Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Heidelberg Engineering, Nidek, Optos, Topcon, and Zeiss. Show Less Read more